Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can shorter feeding times help ICU patients? new study explores safety and feasibility.

NCT ID NCT06741761

Knowledge-focused Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a 12-hour feeding schedule to the usual 24-hour schedule in 20 critically ill adults in the ICU. Researchers want to see if the shorter schedule is safe and works well, looking at feeding tolerance, blood sugar control, and sleep. The goal is to gather knowledge to improve care for ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥18 years of age) * With critical illness (hospitalized in an intensive care unit with a status of "ICU") * Who have received orders for continuous enteral nutrition Exclusion Criteria: * "Comfort Measures Only" status * Have orders to receive trickle feedings (feeding rate ≤10mL/hr) * Recent surgical procedure on the GI tract (within previous 5 days at time of recruitment) or admission for GI bleed * Receiving continuous sedation * Expected to undergo a procedure requiring removal of study devices in the three days following enrollment * History of malabsorptive bariatric surgery * Admitted for a burn injury * Known intolerance to feeding rates \>100mL/hr * Current diagnosis of pancreatitis, ileus or gastroparesis (only if using a gastrostomy tube) * Requiring intermittent or continuous renal replacement therapy * Pregnant or lactating * On an intermittent feeding schedule * Nutritional needs would require a rate higher than 120mL/hr on TRF12 protocol * Lack of clearance by primary physician

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness Intermittent Fasting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness

Contacts and locations

Locations

  • University Of Kansas Health System

    Kansas City, Kansas, 66103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.